Royal DSM

Patheon files registration for Initial Public Offering

Wednesday, June 10, 2015 11:16 AM

Patheon, a CRO based in Durham, N.C., has filed a registration statement with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.

More... »


DPx launched by JLL Partners, Royal DSM

Wednesday, March 12, 2014 01:43 PM

JLL Partners and Royal DSM have launched DPx Holdings, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

More... »


Royal DSM, JLL create jointly owned CDMO

Wednesday, November 20, 2013 12:48 PM

JLL Partners, a middle-market private equity firm, and Royal DSM, a global life sciences and materials sciences company, have created a new global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of around $2 billion. It will be 51% owned by JLL and 49% owned by DSM.

More... »

Almac, DSM sign collaboration agreement in biocatalysis

Wednesday, October 10, 2012 12:24 PM

Global service provider Almac has signed a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, in the field of biocatalysis to provide sustainable manufacturing services to the pharmaceutical industry.

More... »

DSM inks South American biologics contract manufacturing agreement

Monday, July 23, 2012 12:46 PM

DSM Pharmaceutical Products, a custom manufacturing and technology business of Royal DSM, has signed a biologics contract manufacturing agreement with its first Brazilian client, Recepta Biopharma, a Sao Paulo-based biotechnology company focused on monoclonal antibodies to treat cancer.

More... »


CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs